<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02827032</url>
  </required_header>
  <id_info>
    <org_study_id>CRD0328</org_study_id>
    <nct_id>NCT02827032</nct_id>
  </id_info>
  <brief_title>Controlling and Lowering Blood Pressure With the MobiusHD™</brief_title>
  <acronym>CALM-DIEM</acronym>
  <official_title>Controlling and Lowering Blood Pressure With the MobiusHD™ - Defining Efficacy Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vascular Dynamics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vascular Dynamics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      To perform post-market surveillance and evaluate the performance of the MobiusHD System in
      subjects with primary resistant hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CALM-DIEM Trial is an open-label, prospective, multicenter study for patients who have
      been selected for treatment with the MobiusHD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the mean 24-hour systolic Ambulatory Blood Pressure Measurement (ABPM) from Baseline to ninety (90) days post treatment</measure>
    <time_frame>Baseline to ninety (90) days post treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of SAEs and UADEs reported for the population from implantation through three (3) years of follow-up.</measure>
    <time_frame>Baseline to three (3) years post treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>MobiusHD™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The MobiusHD device is a self-expanding nitinol implant that is delivered intravascularly to the internal carotid sinus via the delivery catheter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MobiusHD™</intervention_name>
    <description>The MobiusHD device is a self-expanding nitinol implant that is delivered intravascularly to the internal carotid sinus via the delivery catheter.</description>
    <arm_group_label>MobiusHD™</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mean 24-hour systolic ABPM is ≥130 mmHg following at least 30 days on a stable
             antihypertensive medication regimen (no changes in medication or dose), and no more
             than 28 days prior to implantation.

        Exclusion Criteria:

          -  Known or clinically suspected baroreflex failure or autonomic neuropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sujith J Shetty, MBBS</last_name>
    <phone>01-650-963-9370</phone>
    <email>sshetty@vasculardynamics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Württemberg</state>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Lochbühler</last_name>
      <phone>+49 621 3832339</phone>
      <email>marina.lochbuehler@umm.de</email>
    </contact>
    <investigator>
      <last_name>Bernhard Krämer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CVC Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hesse</state>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine de Bruijn</last_name>
      <phone>+49 69 97947653</phone>
      <email>s.debruijn@cvcfrankfurt.de</email>
    </contact>
    <investigator>
      <last_name>Horst Sievert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <state>Lower Saxony</state>
        <zip>30451</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Bahlmann</last_name>
      <phone>+49 511 532 3000</phone>
      <email>bahlmann.elisabeth@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Bärbel Boes</last_name>
      <phone>+49 511 532 3000</phone>
      <email>boes.baerbel@mh-hannover.de</email>
    </contact_backup>
    <investigator>
      <last_name>Florian Limbourg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniklinik Köln</name>
      <address>
        <city>Cologne</city>
        <state>North Rhine-Westphalia</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatjana Schewior</last_name>
      <phone>+49 221 47888273</phone>
      <email>tatjana.schewior@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Hannes Reuter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <state>North Rhine-Westphalia</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Schmidt, Dr.</last_name>
      <phone>+49 2118108074</phone>
      <email>claudia.schmidt@med.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Christian Rump, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johannes Stegbauer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Krieter</last_name>
      <phone>+49 431 50016547</phone>
      <email>sabine.krieter@uksh.de</email>
    </contact>
    <investigator>
      <last_name>Fritz Wodarg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christl Harsch-Gladisch</last_name>
      <phone>+49 30450514507</phone>
      <email>christl.harsch-gladisch@charite.de</email>
    </contact>
    <investigator>
      <last_name>Markus van der Giet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HagaZiekenhuis</name>
      <address>
        <city>The Hague</city>
        <state>AA</state>
        <zip>2545</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rene Vermaire</last_name>
      <phone>+31 70 210 2143</phone>
      <email>m.vermaire@hagaziekenhuis.nl</email>
    </contact>
    <contact_backup>
      <last_name>Yorik Visser</last_name>
      <phone>+31 70 210 2143</phone>
      <email>y.visser@hagaziekenhuis.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Irene van der Meer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <state>EM</state>
        <zip>3435</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilona Rost</last_name>
      <phone>+31 30 609 2278</phone>
      <email>i.rost@antoniusziekenhuis.de</email>
    </contact>
    <investigator>
      <last_name>Jan van der Heijden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC+</name>
      <address>
        <city>Maastricht</city>
        <state>HX</state>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Jongen-Vancraybex</last_name>
      <phone>+31 43 387 73 66</phone>
      <email>h.jongen@mumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Ellen Herben</last_name>
      <phone>+31 43 387 73 66</phone>
      <email>e.herben@mumc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Bram A.A. Kroon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radboud University Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Saini-Biegel</last_name>
      <phone>31 024 3617 058</phone>
      <email>karin.saini@radbouumc.nl</email>
    </contact>
    <investigator>
      <last_name>Joost Rutten, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3508 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Klaassen</last_name>
      <phone>+31 88 7559954</phone>
      <email>i.klaassen@umcutrecht.nl</email>
    </contact>
    <contact_backup>
      <last_name>Corina Joosten</last_name>
      <phone>+31 88 7559954</phone>
      <email>C.A.M.Joosten@umcutrecht.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Wilko Spiering, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Isala</name>
      <address>
        <city>Zwolle</city>
        <zip>8025AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dick Beuving</last_name>
    </contact>
    <investigator>
      <last_name>Jan-Evert Heeg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2016</study_first_submitted>
  <study_first_submitted_qc>July 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2016</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

